213 related articles for article (PubMed ID: 21536850)
1. Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice.
Hall ME; Smith G; Hall JE; Stec DE
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H253-60. PubMed ID: 21536850
[TBL] [Abstract][Full Text] [Related]
2.
Wang X; Lauth A; Wan TC; Lough JW; Auchampach JA
Dis Model Mech; 2020 Dec; 13(12):. PubMed ID: 33106234
[TBL] [Abstract][Full Text] [Related]
3. 4-hydroxytamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic mice.
Heinen A; Gödecke S; Flögel U; Miklos D; Bottermann K; Spychala A; Gödecke A
Basic Res Cardiol; 2021 Feb; 116(1):8. PubMed ID: 33544211
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity.
Hall ME; Smith G; Hall JE; Stec DE
Am J Physiol Regul Integr Comp Physiol; 2012 Dec; 303(12):R1241-50. PubMed ID: 23115124
[TBL] [Abstract][Full Text] [Related]
5. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.
Sohal DS; Nghiem M; Crackower MA; Witt SA; Kimball TR; Tymitz KM; Penninger JM; Molkentin JD
Circ Res; 2001 Jul; 89(1):20-5. PubMed ID: 11440973
[TBL] [Abstract][Full Text] [Related]
6. A Murine Myh6MerCreMer Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction.
Yan J; Zhang L; Sultana N; Park DS; Shekhar A; Bu L; Hu J; Razzaque S; Cai CL
PLoS One; 2015; 10(7):e0133472. PubMed ID: 26204265
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 expression protects the heart from acute injury caused by inducible Cre recombinase.
Hull TD; Bolisetty S; DeAlmeida AC; Litovsky SH; Prabhu SD; Agarwal A; George JF
Lab Invest; 2013 Aug; 93(8):868-79. PubMed ID: 23732814
[TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.
Andersson KB; Winer LH; Mørk HK; Molkentin JD; Jaisser F
Transgenic Res; 2010 Aug; 19(4):715-25. PubMed ID: 19894134
[TBL] [Abstract][Full Text] [Related]
10. Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination.
Petrich BG; Molkentin JD; Wang Y
FASEB J; 2003 Apr; 17(6):749-51. PubMed ID: 12594183
[TBL] [Abstract][Full Text] [Related]
11. Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart.
Liu R; Khalil H; Lin SJ; Sargent MA; York AJ; Molkentin JD
PLoS One; 2016; 11(10):e0164897. PubMed ID: 27764156
[TBL] [Abstract][Full Text] [Related]
12. Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice.
Hougen K; Aronsen JM; Stokke MK; Enger U; Nygard S; Andersson KB; Christensen G; Sejersted OM; Sjaastad I
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1671-8. PubMed ID: 20802136
[TBL] [Abstract][Full Text] [Related]
13. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice.
Zhong ZA; Sun W; Chen H; Zhang H; Lay YE; Lane NE; Yao W
Bone; 2015 Dec; 81():614-619. PubMed ID: 26232373
[TBL] [Abstract][Full Text] [Related]
14. Inducible gene targeting in postnatal myocardium by cardiac-specific expression of a hormone-activated Cre fusion protein.
Minamino T; Gaussin V; DeMayo FJ; Schneider MD
Circ Res; 2001 Mar; 88(6):587-92. PubMed ID: 11282892
[TBL] [Abstract][Full Text] [Related]
15. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.
Koitabashi N; Bedja D; Zaiman AL; Pinto YM; Zhang M; Gabrielson KL; Takimoto E; Kass DA
Circ Res; 2009 Jul; 105(1):12-5. PubMed ID: 19520971
[TBL] [Abstract][Full Text] [Related]
16. Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase.
Werfel S; Jungmann A; Lehmann L; Ksienzyk J; Bekeredjian R; Kaya Z; Leuchs B; Nordheim A; Backs J; Engelhardt S; Katus HA; Müller OJ
Cardiovasc Res; 2014 Oct; 104(1):15-23. PubMed ID: 25082846
[TBL] [Abstract][Full Text] [Related]
17. Optimization of tamoxifen-induced Cre activity and its effect on immune cell populations.
Donocoff RS; Teteloshvili N; Chung H; Shoulson R; Creusot RJ
Sci Rep; 2020 Sep; 10(1):15244. PubMed ID: 32943672
[TBL] [Abstract][Full Text] [Related]
18. Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response.
Chambers KT; Leone TC; Sambandam N; Kovacs A; Wagg CS; Lopaschuk GD; Finck BN; Kelly DP
J Biol Chem; 2011 Apr; 286(13):11155-62. PubMed ID: 21321124
[TBL] [Abstract][Full Text] [Related]
19. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
20. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]